About this podcast

In this insightful episode, Dr. Andrew Huberman hosts Dr. Matthew Johnson, a leading Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. They delve into the cutting-edge medical research surrounding psychedelic compounds such as psilocybin, MDMA, ayahuasca, DMT, and LSD. The discussion covers how these powerful substances are being clinically trialed for treating a range of mental health conditions, including depression, addiction, trauma, eating disorders, and ADHD. Dr. Johnson meticulously details the typical psychedelic experiment conducted in his lab, emphasizing optimal clinical outcomes and crucial safety considerations, including potential hazards, misconceptions, and risks for specific demographics. The conversation also explores the neurobiological mechanisms, the evolving legal landscape, and the future trajectory of psychiatric medicine, offering unparalleled insights into how psychedelics could redefine our sense of self and reality as part of integrated psychiatric treatments. Listeners will gain a comprehensive understanding of both the immense potential and critical caveats associated with psychedelic-assisted therapy.